Pfizer: authorization of Paxlovid in the United Kingdom


(CercleFinance.com) – After a favorable expert opinion, the Medicines and Health Products Regulatory Agency (MHRA) in the United Kingdom announces the authorization of Paxlovid, an oral antiviral drug developed by Pfizer for the treatment of Covid-19.

‘The product has been shown to be safe and effective in reducing the risk of hospitalization and death in people with mild to moderate Covid-19 infection who are at increased risk of developing serious illness,’ explains the British health authority.

Its use has been authorized for use in people aged 18 and over who have a mild to moderate infection and at least one risk factor for developing serious illness, such as obesity, advanced age (over 60 years), diabetes mellitus or heart disease.

Copyright © 2021 CercleFinance.com. All rights reserved.

Did you like this article ? Share it with your friends with the buttons below.


Twitter

Facebook
Linkedin
E-mail





Source link -85